Crescent Grove Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,304
Closed -$211K 276
2021
Q2
$211K Buy
+1,304
New +$211K 0.02% 242